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2003; Moloney et al., 2000). Moreover, 
there are other proteins with multiple EGF 
domains, but Notch appears to be unique 
in its functional requirement for Ofut1 and 
rumi. Once the structural basis for their 
influence is determined, the logic behind 
this may become clear. For now, the dis-
covery of the rumi O-glucosyltransferase 
is another sweet success from studies of 
Notch signaling in the fly.
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Signal transduction is initiated when a cytokine binds to the extracellular domains of its receptors, 
bringing them together and triggering a complicated sequence of events inside the cell. In this 
issue, LaPorte et al. (2008) present crystal structures of three signaling complexes of the cytokines 
interleukin-4 and interleukin-13 with their receptors, showing how events taking place outside the 
cell may affect the specificity of signal transduction.Signaling by the cytokines interleukin-4 
(IL-4) and interleukin-13 (IL-13) is criti-
cal for T cell development and T cell-
mediated immune responses, including 
allergy. IL-4 and IL-13 signal through a 
heterotrimeric complex consisting of the 
cytokine and two receptors. The recep-
tor complexes for IL-4 come in two vari-
eties, type I and type II. Type I receptor 
complexes comprise the IL-4Rα and 
γ-chain (γc) subunits. The presence of the 
γc subunit defines type I complexes and 
γc is present in receptor complexes for at 
least six different cytokines (Kelly-Welch 
et al., 2003). The type II receptor for IL-4 
is a complex of IL-4Rα and IL-13Rα1, 
which also serves as a receptor for IL-13. 
However, despite signaling through the 
same type II receptor, IL-4 and IL-13 ini-
tiate distinct signaling responses even 
in the same cell types. In this issue, 
LaPorte et al. (2008) present crystal structures of the complexes of IL-4 and 
IL-13 with their soluble receptors. Their 
findings reveal how the γc receptor might 
be able to function in multiple cytokine 
signaling complexes and show how dif-
ferent ligands can mediate distinct sig-
naling responses from a shared set of 
receptors.
The first picture of an interaction 
between a growth factor and a receptor 
was revealed more than 15 years ago with 
the pioneering publication of the struc-
ture of a signaling complex of human 
growth hormone (hGH) and the extracel-
lular soluble domains of its receptor GHR 
(de Vos et al., 1992). A single molecule 
of hGH binds to equivalent regions of 
two receptor molecules, forcing them to 
form dimers. Structural and biochemical 
data supported the notion that the sig-
naling complex formed sequentially. The 
first step involved binding of hGH to one Cell 132receptor molecule, forming the ligand-
receptor interface I (Figure 1A). In the 
second step, another receptor molecule 
binds to the ligand through the interface 
site II. Only a few other crystal structures 
before or since have had such an impact 
and explained as much.
With the availability of the hGH/GHR 
structure, as well as crystal structures of 
free cytokines (Rozwarski et al., 1994), a 
plethora of models of other complexes 
have been generated, including that of 
IL-4 with its receptors (Gustchina et al., 
1995). Although these models explain at 
least some of the signaling properties 
correctly, subsequent crystal structures, 
including a binary complex of IL-4 and 
IL-4α (Hage et al., 1999), have shown 
them to be oversimplified. In addition, 
understanding the close structural and 
biological relationships between differ-
ent cytokines, such as IL-4 and IL-13, has , January 25, 2008 ©2008 Elsevier Inc. 179
figure 1. complexes of Helical cytokines and their Receptors
(A) Complex of human growth hormone (hGH) with two identical receptor (GHR) molecules. The complex contains two ligand-receptor interfaces (I and II) 
located on the opposite sides of hGH, as well as the third inter-receptor interface (III) formed by the C-terminal regions of the receptors located in the proxim-
ity of the plasma membrane. The arrangement of the receptor molecules in the complex shows approximate two-fold symmetry, although the ligand itself is 
completely asymmetric. 
(B) IL-4 and IL-13 are short four-helix bundle cytokines (Rozwarski et al., 1994; Presnell and Cohen, 1989) sharing 25% sequence identity. Depicted are com-
plexes studied by LaPorte et al. (2008). (Left) The type I complex of IL-4 with IL-4Rα and γc; (middle) the type II complex of IL-4 with IL-4Rα and IL-13Rα1; (right) 
the type II complex of IL-13 with IL-4Rα and IL-13Rα1.been slow to emerge (Obiri et al., 1995). 
That situation, however, is now changing 
with the publication of the new struc-
tures of the ternary complexes of IL-4 
and IL-13 with their receptors (LaPorte et 
al., 2008), which markedly improves our 
understanding of how these cytokines 
induce their signaling cascades.
One of the structures presented by 
LaPorte et al. depicts the complete type 
I complex consisting of IL-4, IL-4Rα1, 
and γc (Figure 1B). The other structures 
represent type II ternary complexes of 
IL-4 and IL-13 bound to the same two 
receptors, IL-4Rα and IL-13Rα1 (Figure 
1B). In all three complexes, IL-4Rα binds 
to the ligand interface, which is struc-
turally equivalent to site II of the hGH/
GHR complex, whereas γc and IL-13Rα 
bind to the equivalent of site I of hGH/
GHR (Figure 1B). In the structure of hGH/
GHR, site I is the high-affinity (primary) 
receptor binding site, whereas site II is 
the weaker (secondary) receptor bind-
ing site. IL-13 behaves in the same way 
as hGH in the hGH/GHR complex. How-
ever, in the complexes of IL-4, both type 
I and type II, it is site II that exhibits high 
affinity and site I exhibits low affinity. 
Interactions between the two receptor 
molecules in each of the three com-
plexes are similar to those in the hGH/
GHR complex. IL-13Rα1 is a unique mol-
ecule that consists of three fibronectin 
type III domains instead of the usual two 
found in IL-4Rα and γc. This additional 
domain was also found to interact with 
the ligands in type II complexes through 
binding site IV (Figure 1B). Similar to the 180 Cell 132, January 25, 2008 ©2008 ElsehGH/GHR complex, the formation of the 
ternary complexes was also found to be 
sequential. At first, the ligand binds to 
the high-affinity receptor (IL-4Rα in the 
case of IL-4 complexes, and IL-13Rα1 in 
the case of IL-13), and only then does the 
low-affinity receptor complete the sig-
naling complex.
A structure of the quaternary complex 
of IL-2 with IL-2Rα, IL-2Rβ, and γc was 
previously determined by the same labo-
ratory (Wang et al., 2005). The interfaces 
of IL-2 and IL-4 with γc are very similar. 
The presence of the structurally equiva-
lent amino acid residues found on the 
surfaces of IL-2 and IL-4 suggests that 
these residues very likely constitute the 
γc recognition motif, which also should 
be present on other cytokines that use 
the γ-chain for signaling.
The structures of LaPorte et al. provide 
a new opportunity to analyze the influ-
ence of the interactions occurring out-
side the plasma membrane on the sig-
naling that occurs inside the cell. It has 
been commonly accepted that the prin-
cipal role of the ligand is simply to bring 
together the appropriate receptors, with 
the subsequent chain of events inside 
the cell already predetermined. Such a 
concept is based on the fact that sev-
eral chimeras of cytokine receptors, with 
swapped extracellular domains, still initi-
ate proper signaling. Examples include 
replacement of the extracellular domain 
of erythropoietin by an equivalent domain 
of prolactin, with the resulting chimera 
providing signals directing formation of 
red blood cells (Socolovsky et al., 1998). vier Inc.Even small polypeptides that are able to 
bind to the erythropoietin receptor can 
initiate signaling (Wrighton et al., 1996). 
However, this mode of receptor activa-
tion does not seem to apply to the type II 
complexes of IL-4 and IL-13. Although the 
complexes of these cytokines with their 
receptors appear to be structurally simi-
lar, their biological role is quite different. 
Binding of both cytokines results in for-
mation of the same IL-4Rα/IL-13Rα1 het-
erodimer, but in one case it is IL-4Rα that 
binds to the ligand first and in the other it 
is IL-13Rα1 that binds first. The different 
order of association in the complex, the 
different affinities, as well as variations 
in the concentration of the ligand and 
the receptors on the plasma membrane 
affect the whole signaling process and 
influence its specificity. Understanding 
exactly how that happens on a molecu-
lar level remains a challenge for both cell 
and structural biologists.
There is so much new that we can 
learn from the work of LaPorte et al., yet 
the overall picture is still not completely 
clear. And we thought we understood it 
all 15 years ago!
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